Huang SM - Search Results

1

Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results.

Huang SM, Harari PM. Huang SM, et al. Invest New Drugs. 1999;17(3):259-69. doi: 10.1023/a:1006384521198. Invest New Drugs. 1999. PMID: 10665478 Review.

2

Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.

Huang S, Peter Rodemann H, Harari PM. Huang S, et al. Recent Results Cancer Res. 2016;198:45-87. doi: 10.1007/978-3-662-49651-0_3. Recent Results Cancer Res. 2016. PMID: 27318681 Review.

3

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.

Morris ZS, Guy EI, Francis DM, Gressett MM, Werner LR, Carmichael LL, Yang RK, Armstrong EA, Huang S, Navid F, Gillies SD, Korman A, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM. Morris ZS, et al. Cancer Res. 2016 Jul 1;76(13):3929-41. doi: 10.1158/0008-5472.CAN-15-2644. Epub 2016 May 6. Cancer Res. 2016. PMID: 27197149 Free PMC article.

4

Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models.

Francis DM, Huang S, Armstrong EA, Werner LR, Hullett C, Li C, Morris ZS, Swick AD, Kragh M, Lantto J, Kimple RJ, Harari PM. Francis DM, et al. Clin Cancer Res. 2016 Feb 1;22(3):633-43. doi: 10.1158/1078-0432.CCR-15-1664. Epub 2015 Sep 29. Clin Cancer Res. 2016. PMID: 26420857

5

Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors.

Werner LR, Huang S, Francis DM, Armstrong EA, Ma F, Li C, Iyer G, Canon J, Harari PM. Werner LR, et al. Mol Cancer Ther. 2015 Sep;14(9):1994-2003. doi: 10.1158/1535-7163.MCT-14-1056-T. Epub 2015 Jul 10. Mol Cancer Ther. 2015. PMID: 26162687

6

Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers.

Li C, Huang S, Armstrong EA, Francis DM, Werner LR, Sliwkowski MX, van der Kogel A, Harari PM. Li C, et al. Mol Cancer Ther. 2015 Sep;14(9):2049-59. doi: 10.1158/1535-7163.MCT-15-0155. Epub 2015 Jul 3. Mol Cancer Ther. 2015. PMID: 26141946

7

Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancers.

Huang S, Peet CR, Saker J, Li C, Armstrong EA, Kragh M, Pedersen MW, Harari PM. Huang S, et al. Mol Cancer Ther. 2013 Dec;12(12):2772-81. doi: 10.1158/1535-7163.MCT-13-0587. Epub 2013 Oct 15. Mol Cancer Ther. 2013. PMID: 24130052 Free PMC article.

8

Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma.

Li C, Brand TM, Iida M, Huang S, Armstrong EA, van der Kogel A, Wheeler DL. Li C, et al. Discov Med. 2013 Sep;16(87):79-92. Discov Med. 2013. PMID: 23998444 Free PMC article.

9

Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiation.

Huang S, Li C, Armstrong EA, Peet CR, Saker J, Amler LC, Sliwkowski MX, Harari PM. Huang S, et al. Cancer Res. 2013 Jan 15;73(2):824-33. doi: 10.1158/0008-5472.CAN-12-1611. Epub 2012 Nov 20. Cancer Res. 2013. PMID: 23172311 Free PMC article.

10

Enhancement of radiation response with bevacizumab.

Hoang T, Huang S, Armstrong E, Eickhoff JC, Harari PM. Hoang T, et al. J Exp Clin Cancer Res. 2012 Apr 26;31(1):37. doi: 10.1186/1756-9966-31-37. J Exp Clin Cancer Res. 2012. PMID: 22538017 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results